Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Is Pfizer eyeing a merger with Allergan?

Is Pfizer eyeing a merger with Allergan? Meanwhile, Allergan is still in the throes of major M&A transactions of its own, having merged with Actavis in March in a $70.5bn deal, and since then reached an

The pill branding

The pill branding Lack of strong brands. Only a few patient-oriented brands exist worldwide, including Plan B One Step (Teva), Next Choice One Dose (Actavis), ellaOne (HRA Pharma), My Way (Gavis) and Escapelle

Pharma deals in July 2015

Pharma deals in July 2015 In early 2014 Actavis sold most of its European generics business to Aurobindo and in March 2015 completed the acquisition of Allergan. ... In June Actavis changed its name to Allergan so at this time there was a strong suspicion that Actavis would at

Teva buys Allergan generics unit for $40.5bn

Teva buys Allergan generics unit for $40.5bn Will now drop its six-month pursuit of Mylan

Valeant buys Amoun Pharma for larger slice of MENA market

Valeant buys Amoun Pharma for larger slice of MENA market joined with Actavis.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics